Medication info

Nesinamet 12.5/1000 mg

Prescription medicationTabletOralApproval withdrawn
Ingredient · strength
Alogliptin Benzoate›17mg / 1 tabletMetformin Hydrochloride›1000mg / 1 tablet
Manufacturer / importer
Celltrion Pharm, Inc.
Appearance
Pale yellow, biconvex, film-coated tablets in oblong shape
Packaging
60 tablets (10 tablets/PTP × 6)
Approval status
Approval withdrawn

MFDS item code 201501048 · Approved 2015.02.27

This product's status changed to Approval withdrawn on 2025.05.20. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The dose of this medicine should be adjusted according to efficacy and tolerability, without exceeding the maximum recommended daily doses of each component: alogliptin 25mg and metformin 2000mg. The initial dose of this medicine is determined according to the patient's current treatment regimen. To reduce gastrointestinal adverse reactions associated with metformin use, take this medicine twice daily with meals, and increase the dose gradually. Swallow this medicine whole. 1. Patients not currently receiving metformin The initial dose is 1 tablet of this medicine 12.5/500mg twice daily; the dose may be increased to 1 tablet of this medicine 12.5/1000mg twice daily. 2. Patients with inadequate glycemic control on metformin monotherapy The initial dose of this medicine is alogliptin 12.5mg twice daily (total daily dose 25mg) and the patient's current dose of metformin, according to the patient's current treatment regimen. 3. Patients with inadequate glycemic control on combination therapy with metformin and pioglitazone The initial dose is alogliptin 12.5mg twice daily (total daily dose 25mg), and the initial dose of metformin should be determined taking the patient's blood glucose level and current dose into consideration. 4. Patients with inadequate glycemic control on combination therapy with metformin and insulin The initial dose is alogliptin 12.5mg twice daily (total daily dose 25mg), and the initial dose of metformin should be determined taking the patient's blood glucose level and current dose into consideration. When this medicine is administered concomitantly with insulin, a reduction in the insulin dose may be necessary to reduce the risk of hypoglycemia. 5. Substitution for combination therapy with alogliptin and metformin When switching from combination therapy with alogliptin and metformin to this medicine, treatment may be initiated at the patient's current doses of alogliptin and metformin.

Ingredients

Importer
Celltrion Pharm, Inc.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

View approved original text

This medication assists in controlling blood sugar levels in patients with type 2 diabetes by combining the effects of alogliptin and metformin. When used alongside dietary and exercise therapy, blood sugar levels can be managed more effectively. In other words, this medication helps improve blood sugar control in patients with type 2 diabetes.

How to take

Adult dose

The dose of this medicine should be adjusted according to efficacy and tolerability, without exceeding the maximum recommended daily doses of each component: alogliptin 25mg and metformin 2000mg. The initial dose of this medicine is determined according to the patient's current treatment regimen. To reduce gastrointestinal adverse reactions associated with metformin use, take this medicine twice daily with meals, and increase the dose gradually. Swallow this medicine whole. 1. Patients not currently receiving metformin The initial dose is 1 tablet of this medicine 12.5/500mg twice daily; the dose may be increased to 1 tablet of this medicine 12.5/1000mg twice daily. 2. Patients with inadequate glycemic control on metformin monotherapy The initial dose of this medicine is alogliptin 12.5mg twice daily (total daily dose 25mg) and the patient's current dose of metformin, according to the patient's current treatment regimen. 3. Patients with inadequate glycemic control on combination therapy with metformin and pioglitazone The initial dose is alogliptin 12.5mg twice daily (total daily dose 25mg), and the initial dose of metformin should be determined taking the patient's blood glucose level and current dose into consideration. 4. Patients with inadequate glycemic control on combination therapy with metformin and insulin The initial dose is alogliptin 12.5mg twice daily (total daily dose 25mg), and the initial dose of metformin should be determined taking the patient's blood glucose level and current dose into consideration. When this medicine is administered concomitantly with insulin, a reduction in the insulin dose may be necessary to reduce the risk of hypoglycemia. 5. Substitution for combination therapy with alogliptin and metformin When switching from combination therapy with alogliptin and metformin to this medicine, treatment may be initiated at the patient's current doses of alogliptin and metformin.

Precautions

This medication is a diabetes treatment containing metformin and alogliptin. It should not be used in patients with impaired kidney function or severe heart disease, or liver dysfunction. Particularly, patients with moderate to severe impairment of kidney function or acute illnesses should avoid using this medication. It may cause lactic acidosis, a rare but serious side effect, so if symptoms such as difficulty breathing, muscle pain, weakness, or abdominal pain occur, consult a doctor immediately. Moreover, this medication can induce hypoglycemia, therefore caution is necessary during situations such as skipping meals or engaging in strenuous exercise. Alcohol intake should be avoided while taking this medication, especially excessive drinking could increase the risk of lactic acidosis. When undergoing a radiological examination or surgery requiring iodinated contrast, this medication should be stopped at least 48 hours prior, and it should be resumed only after verifying normal kidney function. Women who are pregnant or breastfeeding should not use this medication, and special attention is needed for children and the elderly. Adverse effects such as gastrointestinal disturbances, headaches, infections, and joint pain may occur in some patients, so report any unusual symptoms to a doctor. Additionally, regular kidney function and blood tests should be conducted during treatment and routine testing is recommended due to the potential risk of Vitamin B12 deficiency. Because this medication can interact with other drugs, inform your doctor or pharmacist about any other medications you are taking.

Side effects

  • Lactic acidosis
  • hypoglycemia
  • upper respiratory infection
  • nasopharyngitis
  • diarrhea
  • hypertension
  • headache
  • low back pain
  • urinary tract infection
  • pancreatitis
Show 129 more
  • hypersensitivity reaction
  • serum sickness
  • nausea
  • vomiting
  • bloating
  • asthenia
  • dyspepsia
  • abdominal discomfort
  • tendinitis
  • fracture
  • costochondritis
  • leg fracture
  • upper extremity fracture
  • spinal fracture
  • rhabdomyolysis
  • acute pancreatitis
  • gastric ulcer
  • exacerbation of gastritis
  • hemorrhagic gastric ulcer
  • appendicitis
  • hyperglycemia
  • exacerbation of diabetes
  • acidosis
  • abscess
  • infection
  • wound defect
  • thyroid carcinoma
  • lung cancer
  • pulmonary carcinoma
  • chest discomfort
  • systemic edema
  • systemic weakness
  • dyspnea
  • exacerbation of asthma
  • exacerbation of pneumonia
  • respiratory arrest
  • acute renal failure
  • kidney stones
  • renal dysfunction
  • liver cirrhosis
  • cholelithiasis
  • myocardial infarction
  • angina pectoris
  • anorexia
  • cerebral infarction
  • transient ischemic attack
  • laceration
  • exacerbation of atrial fibrillation
  • speech disturbance
  • paresthesia
  • sensory disturbance
  • thigh sensory disturbance
  • fecal incontinence
  • tremor
  • numbness
  • neuropathic pain
  • spinal canal stenosis
  • cutaneous sensory disturbance
  • dizziness
  • vertigo
  • lightheadedness
  • ligament injury
  • arthralgia
  • myofascial pain
  • muscle cramps
  • myalgia
  • leg weakness syndrome
  • malaise
  • trigger finger
  • plantar fasciitis
  • tendon rupture
  • arthropathy
  • pruritus
  • contact dermatitis
  • itching
  • keratosis
  • sclerosis
  • increased sweating
  • nail disease
  • otitis externa
  • roseola
  • rosacea
  • furunculosis
  • seborrheic dermatitis
  • conjunctivitis
  • glaucoma
  • macular degeneration
  • cataract
  • keratitis
  • retinal disease
  • retinal disorder
  • retinal disease
  • cystitis
  • exacerbation of cystitis
  • frequent urination
  • neurogenic bladder
  • urethritis
  • hematuria
  • increased serum creatinine
  • biliary sclerosis
  • fatty liver
  • increased AST
  • increased ALT
  • shingles
  • herpes labialis
  • herpes virus infection
  • prostate enlargement
  • benign prostatic hyperplasia
  • depression
  • hypersensitivity
  • erectile dysfunction
  • insomnia
  • sleep disorder
  • orthostatic hypotension
  • hypotension
  • tinnitus
  • acute hearing loss
  • Ménière's disease
  • unspecified ear disease
  • coronary artery occlusion
  • exacerbation of angina
  • cataract extraction
  • laceration
  • bradycardia
  • palpitations
  • atrial fibrillation
  • atherosclerosis
  • hypothyroidism
  • nodular goiter

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. It is advisable to maintain storage temperatures between 1 to 30 degrees Celsius at room temperature. This helps to preserve the medication's effectiveness for a longer time.

Appearance and packaging

Appearance

Pale yellow, biconvex, film-coated tablets in oblong shape

Package unit

60 tablets (10 tablets/PTP × 6)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.